Two cases of prostate cancer with disseminated carcinomatosis of the bone marrow treated with novel hormonal agents.

Keina NozakiHisashi MatsushimaHiyo ObikaneRyohei NishimotoRyo TanakaTakeru MorishigeTomoko MasudaHaruki Kume

Published in: IJU case reports (2023)

These results suggest that novel hormonal agents may improve the prognosis of prostate cancer even in patients with disseminated carcinomatosis of the bone marrow.

Keyphrases

prostate cancer
bone marrow
radical prostatectomy
mesenchymal stem cells
polycystic ovary syndrome
skeletal muscle